As we kick off the new year, we at Deep 6 AI are looking forward to more opportunities to meet with our peers in the clinical research community. It’s been a tough couple of years for everyone, but especially for those in healthcare, which is why being able to connect again in person is...
Pasadena, Calif. – [June 29, 2021] — Deep 6 AI, the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), today announced significant growth with the addition of key customer wins and an expanding executive leadership team. Experienced software and technology leaders Chris Brubaker...
The shift to electronic medical records (EMRs) through health care has opened up possibilities for mining those data for many purposes, including clinical trial recruitment and feasibility assessments. However, as more systems access this sensitive electronic protected health information (ePHI), data security is often top...
Using AI to solve some of the greatest barriers to healthcare innovation: clinical trial recruitment and retention In the most recent issue of Delta Magazine, Natasha Cowan talked with our CEO Wout Brusselaers about Deep 6 AI, our technology, and the clinical trial industry pain...
AI-powered technology can access the 90% of medical records (unstructured data) untouched by other systems Did you know that nearly nine out of ten clinical trials suffer significant delays, slowing down the clinical innovation they aim to support. Trial criteria have exploded in size and complexity...
Successful Clinical Trial Feasibility and Design in Near Real Time: Using AI-enabled Precision Matching Technologies to Ensure Accurate Patient Populations at Cedars-Sinai In our recent webinar, BJ Rimel, MD, assistant professor at Cedars-Sinai, and Deep 6 AI experts Shabnam Shademan, Ph.D., and Allison Tyler, BSN,...
Rare Disease Day is February 28, 2021, which aims to raise awareness of rare diseases and the patients living with them. An astounding 25% of patients with a rare disease can wait 5 - 30 years for an initial diagnosis, and for 40% of patients,...
On October 12-13, the Association of American Cancer Institutes (AACI) and the Cancer Center Administrators Forum (CCAF) are coming together for their 2020 AACI/CCAF Annual Meeting. Deep 6 AI will be virtually exhibiting at the event from 8am - 3:30pm EST among other participants discussing...
The COVID pandemic is shining a light on a long-standing and well-documented issue in clinical trials – a lack of diversity. Currently, it’s putting critical research like the COVID vaccine at risk, as trials struggle to recruit Black and Latinx participants, despite the fact that...
With such tight budgets in healthcare organizations, investigators must get creative to be able to execute their research goals. For academic medical institutions and research hospitals, applying for grants can be a daunting yet crucial aspect of the process to getting a clinical trial up...